Moreover, this study predominantly focuses on cellular levels and in vitro experiments; future research should incorporate more in vivo studies to comprehensively validate the role of the WISP1-CAFs axis in ESCC animal models and explore potential therapeutic strategies based on this axis. The gene discussed is CCN4; the disease is esophageal squamous cell carcinoma.